University of Gaziantep Hospital
Gaziantep, 27310, Turkey (Türkiye)
NCT Number: NCT01580085
Obstructive sleep apnea (OSA) is a clinical syndrome characterized by repetitive closure of the airway and frequent awakenings during sleep. Repeated episodes of hypoxia, decrease in intrathoracic pressure, increased venous return and venous stasis, damage to vascular wall may ensue. An increased tendency for coagulation has also been reported in OSA. Venous stasis, vascular endothelial activation and hypercoagulability are also known risk factors for thromboembolism. All of these pathophysiologic changes in OSA may predispose patients for the development of pulmonary embolism (PE) however there is limited data about role of thromboembolic events in OSA.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Gaziantep, 27310, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
full night supervised laboratory polysomnography
Other names: PSG
University of Gaziantep
Other
Obstructive Sleep Apnea is Prevalent in Patients With Pulmonary Embolism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05111613
Cardiovascular Diseases, Embolism
Loma Linda, California, United States
View Trial DetailsNCT02616991
Cardiovascular Diseases, Embolism
Paris, France
View Trial DetailsNCT03595891
Cardiovascular Diseases, Embolism
Cardiff, United Kingdom
View Trial DetailsNCT01513759
Acute Pulmonary Embolism, Cardiovascular Diseases
Montgomery, Alabama, United States
View Trial Details